Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand

December 2, 2013

AMSTERDAM, December 2, 2013 /PRNewswire/ –

CPhI announces that CPhI and P-MEC India, run by leading events organiser UBM, is
returning to the Bombay Convention and Exhibition Centre, Mumbai (India) from the 3rd to
the 5th December 2013. The event will return with an increased scale, continuing its
commitment to cater to all sectors of the pharma industry by co-locating with ICSE and
BioPh India.

(Logo:
http://photos.prnewswire.com/prnh/20130723/629764-a )

With a view to enhancing the customer experience and ROI value, CPhI India has
enhanced the mobile application, now available on all mobile devices with an internet
connection, designed to help attendees navigate their way around the event, drive traffic
to stands and stay up to date with schedules and speaker events.

With the addition of hall 7, P-MEC will host even more exhibitors than previous years.
Last year, there were 926 exhibitors present and this is expected to rise to 1,000 this
year to create the biggest show to date. Free online registration to attend CPhI and P-MEC
India is now closed, however registration is still possible in Mumbai, the onsite fee is
only INR500.

India has increasingly become a focal point of the pharmaceutical industry and is now
the third largest in terms of volume. The country is fast becoming an innovation hub,
increasingly matching Western standards, whilst also reducing the costs of manufacturing,
showcasing the Indian pharma markets unique position and providing an optimum investment
platform for international companies. Outside of the US, India has the highest number of
FDA approved facilities (546), and the Indian pharma sector received USFDA approvals for
around 40% of all Abbreviated New Drug Approvals (ANDA) during January-July 2013. Further,
with R&D investments rapidly advancing, coupled with the rise in generics and
supergenerics, India represents a key maturing market, with CPhI and P-MEC India
facilitating opportunities to drive and enhance the sector.

Ahead of the event, the UBM India pharma awards will take place on 2nd December,
celebrating the most innovative and dynamic areas across the Indian pharma community.
Honouring companies who are driving forward industry changing initiatives, there will be
awards for multiple categories including ‘Excellence in Product Development’, ‘Excellence
in Contract Research’ and ‘Excellence in Packaging Development’. The evening will also
host a panel discussion on ‘Moving up the Global Pharma Value Chain’, designed to inform
and educate those present at the awards ceremony.

“The global pharmaceutical market has seen a significant shift over the last year,
particularly as patent expirations are becoming more frequent and a potential patent cliff
is shaking the industry. India, however, is thriving as the demand for generics is on the
rise and companies are looking to drive down manufacturing costs. India is well positioned
to accommodate increased demand, providing expertise in development and manufacturing.
CPhI and P-MECIndia will provide the ideal and essential platform for international and
domestic suppliers and buyers to break into the market.” – Chris Kilbee, Group Director,
Pharma.

Notes to editors

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply
chain from drug discovery to finished dosage. Through exhibitions, conferences and online
communities, CPhI brings together more than 100,000 pharmaceutical professionals each year
to network, identify business opportunities and expand the global market. CPhI hosts
events in Europe, China, India, Japan, Southeast Asia, Russia and South America co-located
with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for
pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier
directory at CPhI-Online.com and hosts a global community with news and analysis at
PharmaEvolution.com.

For more information visit: http://www.cphi.com

The UBM Live annual schedule of Pharmaceutical events also includes CPhI, ICSE, P-MEC,
BioPh and Pharmatec Japan (9-11 April, 2014 in Tokyo); CPhI Russia and IPhEB (16-17 April,
2014 in St Petersburg, Russia); CPhI, P-MEC and Innopack South East Asia (20-22 May, 2014
in Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, Turkey) and CPhI, Hi and Fi, ICSE,
P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC, Shanghai, China), CPhI South
America (5-7 August 2014 at Expo Centre Norte, Sao Paulo – Brazil); CPhI Worldwide, ICSE,
P-MEC Europe and InnoPack (7-9 October, 2013 at Nord Ville Pinte Paris, France)

        For media enquiries, please contact:

        Alex Heeley or Tristan Jervis
        De Facto Communications
        T: +44(0)207-203-6745
        E: a.heeley@defacto.com, t.jervis@defacto.com


    Photo: 

http://photos.prnewswire.com/prnh/20130723/629764-a

SOURCE UBM Live


Source: PR Newswire